Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using a Thiazolidinedione or a Thiazolidinedione and Metformin
Phase of Trial: Phase III
Latest Information Update: 18 Sep 2015
At a glance
- Drugs Exenatide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Amylin Pharmaceuticals
- 24 Sep 2010 Primary endpoint 'Proportion of glycosylated haemoglobin' has been met, according to results reported at the 46th Annual Meeting of the European Association for the Study of Diabetes.
- 24 Sep 2010 Results were reported at the 46th Annual Meeting of the European Association for the Study of Diabetes.
- 17 Sep 2010 Actual end date (Jul 2009) added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History